Global Footprint for Late Phase Oncology Trials
Catalyst Oncology understands multinational drug development. We are able to move forward Phase II and Phase III studies across the globe with our network of skilled clinical trial professionals and patient recruitment experts.
We are here because every second counts with cancer research. Through our global footprint, we offer essential deep therapeutic and functional expertise, ingenuity, and substantial transparency.
The project team anticipates and provides solution-based responses to the current challenges on a given study, which is the essential need for any Sponsor as each protocol evolves and changes based on the clinical data collected.
My Catalyst team is an extension of my internal team. The team is very transparent and communicative. They are aware of the trial timelines and each department helps to keep the study on track.